Leadership in health care private equity since 1986

The Latest News

November 07, 2018

TriSalus Life Sciences’ Pressure-Enabled Drug Delivery (PEDD) Significantly Increased Therapeutic Effect of Anti-CEA CAR-T in Pancreatic Cancer Patients with Liver Metastases>

  • PEDD overpowers intratumoral high pressure, significantly increasing CAR-T into solid tumors
  • Median overall survival (OS) 8.3 months and mean OS 9.8 months vs. 3 to 6 months standard of care
  • Two of four stage IV patients who failed systemic chemotherapy showed metabolic complete response (CR); no visible liver metastases on PET
November 05, 2018

SupplyPro Named to Silicon Review's 50 Best Workplaces 2018>

Developing investory management solutions to improve manufacturing profitability and streamline operations.

November 01, 2018

SupplyPro® Unveils New SupplySystem Intelligent Software™ for Inventory Management>

SupplySystem IS Leverages Advanced Technologies to Deliver a Competitive Advantage

October 26, 2018

TriSalus Life Sciences Names Chief Business Officer>

Leadership appointment supports strategic shift to build oncology drug delivery company

October 23, 2018

NICE Publishes Advice on gammaCore for the Treatment of Cluster Headache in the UK>

Report contributors agreed gammaCore was highly innovative, may be more effective than standard of care alone, and has the potential to save money through the NHS by reducing the cost of treating cluster headache.

October 12, 2018

Exagen Announces Launch of Novel Biomarker PC4d Associated with Thrombosis in Lupus>

Makers of the rapidly growing AVISE CTD test expands portfolio of patented CB-CAPs blood tests

October 04, 2018

OrthoSensor Announces Milestone of 50,000 VERASENSE™ Sensors Distributed Globally>

VERASENSE is transforming primary and revision total knee replacement for surgeons and patients across the globe.

October 02, 2018

Exagen Featured in Eight Scientific Presentations at The 2018 ACR/ARHP Annual Meeting in Chicago>

Leading immunology laboratory continues strides with first ever economic impact data for AVISE Lupus

September 26, 2018

Alphatec Advances Clinical Distinction With OsseoScrew® Clearance>

Alphatec's OsseoScrew® System received 510(k) clearance from the U.S. Food & Drug Administration (FDA), making it available for clinical use for the first time in the United States. 

September 12, 2018

Surefire Medical to Change Name to TriSalus Life Science>

New company name better represents contribution to patient care

September 11, 2018

Exagen, Maker of AVISE Testing, Announces First Blood Test for Anti-CarP, a Breakthrough Biomarker for Rheumatoid Arthritis>

Novel test now available to aid in detection and management of widespread debilitating condition 

September 05, 2018

SupplyPro Delivers Absolute Accountability with SupplySystem Scale Module™>

SupplySystem Scale Module Provides Automated Weight-Based Dispensing with Managed Accountability 

August 13, 2018

FDA Accepts New Drug Application (NDA) to review Midazolam Nasal Spray, an investigational product for the acute treatment of seizure clusters>

Midazolam Nasal Spray has been granted orphan drug designation by the United States Food and Drug Administration (US FDA) for the rescue treatment of seizures in patients who require control of intermittent bouts of increased seizure activity. 

August 09, 2018

ElectroCore, Inc. Announces Research Collaboration with Massachusetts General Hospital to Explore Non-Invasive Vagus Nerve Stimulation in Neuroinflammation>

Non-invasive vagus nerve stimulation (nVNS) will be studied in preclinical settings, looking at the effects of this novel therapeutic approach on neuroinflammatory mechanisms which have been associated with conditions in the central nervous system (CNS) including pain, trauma and neurodegeneration.

August 01, 2018

Next Generation nVNS Therapy gammaCore Sapphire™ Now Available for Patients with Migraine and Episodic Cluster Headache in United States>

Innovative technology provides patients with convenient, easy-to-use treatment option without the potential side effects associated with commonly prescribed medicines

July 17, 2018

ElectroCore and UpScript Launch Program to Offer Direct-to-Patient Telemedicine Option for gammaCore™ in the United States>

gammaCore is the first FDA-cleared, nVNS therapy that can be self-administered by patients as needed for the acute treatment of pain associated with migraine and episodic cluster headache. UpScript offers a convenient way for prospective patients to consult with a licensed healthcare provider via telephone or video to find out if they are candidates for gammaCore.

July 13, 2018

New Research Shows Promise in Regional Delivery of CAR-T Therapy>

Authors conclude novel delivery devices should be developed in conjunction with CAR-T therapies

June 11, 2018

Orthosensor Secures Additional 510(K) Clearance>

VERASENSE™ Sensor-Assisted Technology Now Approved for Use with Zimmer Biomet Persona® Knee System, enabling surgeons to improve knee balance and customize implant position during surgery by using intraoperative sensor data.

March 08, 2018

Alphatec Spine Disrupts Market With Acquisition of SafeOp Surgical>

Acquisition provides Alphatec most advanced automated neuromonitoring technology